Sugi Predict

Sugi Predict / Compounds / SCHEMBL28303115

SCHEMBL28303115

SCHEMBL28303115

C[C@@]12C(=CC(=O)C=C1OP(=O)(O)O)CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO.[NaH].[NaH]

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 10/20 0.63
▸ NR3C1 P04150 8/20 0.63
▸ HSD17B10 Q99714 6/20 0.63
▸ PGR P06401 5/20 0.63
▸ CYP3A4 P08684 5/20 0.63
▸ CYP2C19 P33261 3/20 0.63
▸ SERPINA6 P08185 3/20 0.63
▸ NR3C2 P08235 2/20 0.63
▸ AR P10275 2/20 0.63
▸ ABCB11 O95342 2/20 0.63
▸ TNF P01375 1/20 0.63
▸ IL6 P05231 1/20 0.63
▸ GLUL P15104 1/20 0.63
▸ ADAM17 P78536 1/20 0.63
▸ GPBAR1 Q8TDU6 1/20 0.63
▸ KMT2A Q03164 2/20 0.59
▸ SHBG P04278 1/20 0.59
▸ MAPT P10636 1/20 0.59
▸ NFKB1 P19838 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23565 1.00 HIF1A (0.63) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL7513 0.99 HIF1A (0.64) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL16094486 0.93 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL28874596 0.93 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL28596717 0.93 HIF1A (0.55) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL23828321 0.92 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL28388269 0.92 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL1930094 0.92 HIF1A (0.63) HIF1ANR3C1HSD17B10PGRCYP3A4
Phosphoric Acid SCHEMBL27656886 0.90 HIF1A (0.61) HIF1ANR3C1HSD17B10PGRCYP3A4
SCHEMBL26126454 0.89 HIF1A (0.56) HIF1ANR3C1HSD17B10PGRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107865966-A The compound amino glycoside pharmaceutical composition being locally administered 刘力 2018-04-03 — — CN claimed
CN-107854469-A Topical ophthalmic or the husky star medicine of ear or nose use or external preparation for skin and combinations thereof 刘力 2018-03-30 — — CN claimed
CN-109906075-A Liposomal corticosteroids for local injection in inflamed lesions or areas 恩瑟拉德斯医药有限公司 2019-06-18 — — CN disclosed
CN-107865966-A The compound amino glycoside pharmaceutical composition being locally administered 刘力 2018-04-03 — — CN disclosed
CN-107854469-A Topical ophthalmic or the husky star medicine of ear or nose use or external preparation for skin and combinations thereof 刘力 2018-03-30 — — CN disclosed
CN-105392469-A Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives THEMIS MEDICARE LTD 2016-03-09 — — CN disclosed
CN-105073127-A Oral steroid formulations for use in the treatment of intestinal fibrosis SIGMOID PHARMA LTD 2015-11-18 — — CN disclosed
CN-104144679-A LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS IN HUMANS ENCELADUS PHARMACEUTICALS B V 2014-11-12 — — CN disclosed
CN-101862295-A Aggregate having enhanced deformability and including at least three amphipatic substances IDEA AG 2010-10-20 — — CN disclosed
CN-1703199-B Aggregate with enhanced deformability comprising at least three amphiphiles for improved transport through a semi-permeable barrier and use of non-invasive drugs in vivo, in particular through the skin IDEA AG 2010-04-28 — — CN disclosed
CN-1703199-A Aggregate with enhanced deformability comprising at least three amphiphiles for improved transport through a semi-permeable barrier and use of non-invasive drugs in vivo, in particular through the skin IDEA AG (DE) 2005-11-30 — — CN disclosed